Virtually screen billions of compounds to identify optimal drug candidates faster.

"Schrödinger's physics-based simulations have dramatically improved our ability to predict binding affinities. We're identifying more promising hits with fewer false positives."

"The platform allows us to explore chemical space much more efficiently. It's a significant accelerator for our early-stage discovery programs."

"Optimizing ADMET properties used to be a significant bottleneck. Schrödinger's predictive models allow us to address these issues earlier and more effectively."

"While it requires a learning curve, the accuracy of Schrödinger's predictions has proven invaluable in prioritizing synthesis efforts and reducing experimental waste."